These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Successful treatment of cutaneous lesions in juvenile dermatomyositis with high-dose intravenous immunoglobulin. Amano H; Nagai Y; Katada K; Hashimoto C; Ishikawa O Br J Dermatol; 2007 Jun; 156(6):1390-2. PubMed ID: 17459039 [No Abstract] [Full Text] [Related]
23. [Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia]. Ozawa Y; Kurosaka D; Yokoyama T; Tajima N Ryumachi; 2000 Oct; 40(5):798-809. PubMed ID: 11215158 [TBL] [Abstract][Full Text] [Related]
24. Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody. Gossez M; Levesque M; Khouatra C; Cottin V; Garnier L; Fabien N Eur Respir Rev; 2015 Jun; 24(136):370-2. PubMed ID: 26028648 [TBL] [Abstract][Full Text] [Related]
25. Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients. Foreman C; Russo P; Davies N; Hissaria P; Proudman S; Hughes T; Limaye V Intern Med J; 2017 Jan; 47(1):112-115. PubMed ID: 28076913 [TBL] [Abstract][Full Text] [Related]
26. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis. Tanaka F; Origuchi T; Migita K; Tominaga M; Kawakami A; Kawabe Y; Eguchi K Intern Med; 2000 May; 39(5):428-30. PubMed ID: 10830189 [TBL] [Abstract][Full Text] [Related]
27. Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels. Wakiguchi H; Hasegawa S; Hirano R; Kaneyasu H; Wakabayashi-Takahara M; Ohga S Pediatr Rheumatol Online J; 2015 Nov; 13():49. PubMed ID: 26581448 [TBL] [Abstract][Full Text] [Related]
28. [Treatment for polymyositis/dermatomyositis]. Hara M Ryumachi; 1999 Aug; 39(4):670-8. PubMed ID: 10536485 [No Abstract] [Full Text] [Related]
29. Improvement of Calcinosis in Dermatomyositis With Intravenous Immunoglobulin. Sakellariou GT; Katsigianni I J Clin Rheumatol; 2024 Jun; 30(4):e124. PubMed ID: 38527977 [No Abstract] [Full Text] [Related]
30. MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report. Alqatari S; Riddell P; Harney S; Henry M; Murphy G BMC Pulm Med; 2018 Apr; 18(1):59. PubMed ID: 29665800 [TBL] [Abstract][Full Text] [Related]
31. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case]. Girard C; Vincent T; Bessis D Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894 [TBL] [Abstract][Full Text] [Related]
32. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004 [TBL] [Abstract][Full Text] [Related]
33. Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease. Kato Y; Yamamoto T Int J Rheum Dis; 2017 May; 20(5):660-661. PubMed ID: 28397348 [No Abstract] [Full Text] [Related]
34. A case of hypomyopathic dermatomyositis associated with rapid progressive interstitial pneumonia resistant to multi-immunosuppressive therapy. Tsuda T; Asanuma Y; Koyama S; Kawabata Y; Moriguchi M Am J Med Sci; 2007 Mar; 333(3):185-90. PubMed ID: 17496740 [TBL] [Abstract][Full Text] [Related]
35. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Shinohara T; Hidaka T; Matsuki Y; Ishizuka T; Takamizawa M; Kawakami M; Kikuma H; Suzuki K; Nakamura H Intern Med; 1997 Jul; 36(7):519-23. PubMed ID: 9240505 [TBL] [Abstract][Full Text] [Related]